The analysis describes the regulatory options that are available to reduce the risk of an outbreak of BSE in ths US, most of which involve pharmaceuticals.
The regulatory options that are available to reduce the risk of an outbreak of BSE in ths US , most of which involve pharmaceuticals are described by the analysis.